Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1982 Sep;48(3):204–212. doi: 10.1136/hrt.48.3.204

Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.

R F Alvares, J F Goodwin
PMCID: PMC481230  PMID: 6125160

Abstract

Beta adrenergic blocking drugs in hypertrophic cardiomyopathy provide symptomatic relief but their effect on long-term prognosis is uncertain. Thirty patients were studied non-invasively by simultaneous recordings of echocardiogram, apex-cardiogram, phonocardiogram, and electrocardiogram in order to assess diastolic abnormalities on and off oral beta adrenergic blocking drugs. While on treatment these patients had a mean dose of propranolol 200 mg/day. The treatment was stopped for one week and then non-invasive assessment was repeated. The following diastolic time intervals were studied: isovolumic relaxation period (A2-mitral valve opening); rapid relaxation period (A2-O point of the apexcardiogram), and the period from mitral valve opening to the O point of the apexcardiogram (Mo-O) when most of the filling of the left ventricle occurs. The prolongation of the rapid relaxation period reflects a reduced rate of fall of the left ventricular pressure when the pressure differential does not change between A2 and the O point of the apexcardiogram, and in this study this period was prolonged in 19, shortened in eight, and remained the same in three patients after beta blockade. The Mo-O point was prolonged in 22, shortened in seven, and was unchanged in one patient after beta adrenergic blocking drugs. All these results were independent of heart rate. In conclusion the response of diastolic time intervals to beta blocking drugs in hypertrophic cardiomyopathy was variable but there was a significant number of patients in whom the time available for filling of the left ventricle was prolonged, suggesting better filling possibly because of improved distensibility of the left ventricle after beta adrenergic blocking drugs.

Full text

PDF
204

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRAUNWALD E., EBERT P. A. Hemogynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Am J Cardiol. 1962 Oct;10:489–495. doi: 10.1016/0002-9149(62)90373-9. [DOI] [PubMed] [Google Scholar]
  2. Epstein S. E., Braunwald E. Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. N Engl J Med. 1966 Nov 17;275(20):1106–contd. doi: 10.1056/NEJM196611172752006. [DOI] [PubMed] [Google Scholar]
  3. Frank M. J., Abdulla A. M., Canedo M. I., Saylors R. E. Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol. 1978 Dec;42(6):993–1001. doi: 10.1016/0002-9149(78)90687-2. [DOI] [PubMed] [Google Scholar]
  4. Gibson D. G., Brown D. Measurement of instantaneous left ventricular dimension and filling rate in man, using echocardiography. Br Heart J. 1973 Nov;35(11):1141–1149. doi: 10.1136/hrt.35.11.1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goodwin J. F., Oakley C. M. The cardiomyopathies. Br Heart J. 1972 Jun;34(6):545–552. doi: 10.1136/hrt.34.6.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goodwin J. F. Prospects and predictions for the cardiomyopathies. Circulation. 1974 Aug;50(2):210–219. doi: 10.1161/01.cir.50.2.210. [DOI] [PubMed] [Google Scholar]
  7. Goodwin J. F. Treatment of the cardiomyopathies. Am J Cardiol. 1973 Sep 7;32(3):341–351. doi: 10.1016/s0002-9149(73)80144-4. [DOI] [PubMed] [Google Scholar]
  8. HOLLISTER R. M., GOODWIN J. F. The electrocardiogram in cardiomyopathy. Br Heart J. 1963 May;25:357–374. doi: 10.1136/hrt.25.3.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hammermeister K. E., Warbasse J. R. The rate of change of left ventricular volume in man. II. Diastolic events in health and disease. Circulation. 1974 Apr;49(4):739–747. doi: 10.1161/01.cir.49.4.739. [DOI] [PubMed] [Google Scholar]
  10. Hardarson T., De la Calzada C. S., Curiel R., Goodwin J. F. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet. 1973 Dec 29;2(7844):1462–1467. doi: 10.1016/s0140-6736(73)92730-x. [DOI] [PubMed] [Google Scholar]
  11. Horwitz L. D., Bishop V. S. Left ventricular pressure-dimension relationships in the conscious dog. Cardiovasc Res. 1972 Mar;6(2):163–171. doi: 10.1093/cvr/6.2.163. [DOI] [PubMed] [Google Scholar]
  12. Hubner P. J., Ziady G. M., Lane G. K., Hardarson T., Scales B., Oakley C. M., Goodwin J. F. Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. Br Heart J. 1973 Nov;35(11):1116–1123. doi: 10.1136/hrt.35.11.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Popp R. L., Harrison D. C. Ultrasound in the diagnosis and evaluation of therapy of idiopathic hypertrophic subaortic stenosis. Circulation. 1969 Dec;40(6):905–914. doi: 10.1161/01.cir.40.6.905. [DOI] [PubMed] [Google Scholar]
  14. Porter C. M., Baxley W. A., Eddleman E. E., Jr, Frimer M., Rackley C. E. Left ventricular dimensions and dynamics of filling in patients with gallop heart sounds. Am J Med. 1971 Jun;50(6):721–727. doi: 10.1016/0002-9343(71)90180-x. [DOI] [PubMed] [Google Scholar]
  15. Sabbah H. N., Anbe D. T., Stein P. D. Negative intraventricular diastolic pressure in patients with mitral stenosis: evidence of left ventricular diastolic suction. Am J Cardiol. 1980 Mar;45(3):562–566. doi: 10.1016/s0002-9149(80)80005-1. [DOI] [PubMed] [Google Scholar]
  16. Saenz de la Calzada C., Ziady G. M., Hardarson T., Curiel R., Goodwin J. F. Effect of acute administration of propranolol on ventricular function in hypertrophic obstructive cardiomyopathy measured by non-invasive techniques. Br Heart J. 1976 Aug;38(8):798–803. doi: 10.1136/hrt.38.8.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sanderson J. E., Traill T. A., Sutton M. G., Brown D. J., Gibson D. G., Goodwin J. F. Left ventricular relaxation and filling in hypertrophic cardiomyopathy. An echocardiographic study. Br Heart J. 1978 Jun;40(6):596–601. doi: 10.1136/hrt.40.6.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Shah P. M., Gramiak R., Adelman A. G., Wigle E. D. Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis. Circulation. 1971 Nov;44(5):891–898. doi: 10.1161/01.cir.44.5.891. [DOI] [PubMed] [Google Scholar]
  19. Shah P. M. Newer concepts in hypertrophic obstructive cardiomyopathy II. JAMA. 1979 Oct 19;242(16):1771–1776. [PubMed] [Google Scholar]
  20. Swan D. A., Bell B., Oakley C. M., Goodwin J. Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J. 1971 Sep;33(5):671–685. doi: 10.1136/hrt.33.5.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Willems J. L., Denef B., Kesteloot H., De Geest H. Comparability and reproducibility of apex cardiogram recorded with six different transducer systems. Br Heart J. 1979 Jun;41(6):716–726. doi: 10.1136/hrt.41.6.716. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES